English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Studies using 51Cr-labeled platelets have shown reduced platelet survival in patients with artificial cardiac ball valves. Recently, a simple non-radioisotopic method for measuring platelet survival has been developed by Stuart (NEJM 292:1310, 1975) based on the concept that aspirin (ASA) irreversibly inhibits lipid peroxidation of circulating platelets. This method was used to determine platelet survival in 20 control subjects, 8 patients with normally functioning Starr-Edwards artificial cardiac valves (cardiac catheterization 5/8) and 4 patients with documented prosthetic valve dysfunction. The T½ (best fit to an exponential curve) for control subjects was 4.0 ± 0.7 (1 SD) days with a range of 3.0 to 5.6 days. The T½ of normally functioning artificial valves was less than that of the control subjects (3.3 ± 0.3 days, range 3.1 – 3.8 days, p &lt; 0.05). Moreover, the patients with valves that were obstructed or had a peri prosthetic leak had a T½ of 2.7 ± 0.1 days, which was significantly shorter than either the controls or the patients with normally functioning artificial valves (p &lt; 0.01). Two additional valve patients also showed shortened platelet survival (subacute bacterial endocarditis – T½ 2.9 days, acute intimai tear of the aorta – T½ 2.5 days) and 2 patients without prostheses who were taking dipyridamole had normal platelet survival [T½ 4.0, 3.3 days). These results indicate that the ASA method for determining platelet survival identifies shortened platelet survival in patients with artificial cardiac valves and may be a useful non-invasive tool to detect prosthetic valve dysfunction.

Platelet Survival Using Aspirin: Studies in Patients with Artificial Cardiac Valves